| Luke Prosthetic And Orthotic Lab, I | |
| 117 E Wallace St, Findlay, Ohio 45840 | |
| (419) 422-5009 |
| Name | Luke Prosthetic And Orthotic Lab, I |
|---|---|
| Organization Name | Luke Prosthetic And Orthotic Lab, Inc. |
| Location | 117 E Wallace St, Findlay, Ohio 45840 |
| Type | Supplier |
| Phone | (419) 422-5009 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
U.S. Ambassador to Namibia Wanda Nesbitt writes in the State Department's "DipNote" blog, "Here in Namibia, the United States, through the President's Emergency Plan for AIDS Relief (PEPFAR), is working closely with the people and Government of Namibia to prevent new HIV infections, provide lifesaving HIV treatment to those who need it, and help put an end to AIDS in the country."
UNICEF expects children to be among the worst affected by the devastating 7.9 earthquake that struck Nepal today, affecting the area around the capital city of Kathmandu. While the full impact of the disaster is still being assessed, an estimated 40 percent of Nepal's population is children, who are the most vulnerable during emergencies.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 9 days ago
News Archive
U.S. Ambassador to Namibia Wanda Nesbitt writes in the State Department's "DipNote" blog, "Here in Namibia, the United States, through the President's Emergency Plan for AIDS Relief (PEPFAR), is working closely with the people and Government of Namibia to prevent new HIV infections, provide lifesaving HIV treatment to those who need it, and help put an end to AIDS in the country."
UNICEF expects children to be among the worst affected by the devastating 7.9 earthquake that struck Nepal today, affecting the area around the capital city of Kathmandu. While the full impact of the disaster is still being assessed, an estimated 40 percent of Nepal's population is children, who are the most vulnerable during emergencies.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares ("ADSs"), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of 1,800,000 additional ADSs to cover over-allotments.
The coronavirus disease (COVID-19) outbreak has started to gain momentum over the past week, spreading to 77 countries, including Australia. The number of confirmed cases in the country has reached 41, with ten new cases reported in Queensland.
Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.
› Verified 9 days ago
Cvs Pharmacy #05813 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 463 Tiffin Ave, Findlay, Ohio 45840 Phone: (419) 423-3236 | |
Rite Aid Pharmacy 04736 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 301 N Main St, Findlay, Ohio 45840 Phone: (419) 420-9485 | |
Rite Aid Pharmacy 02359 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1501 N Main St, Findlay, Ohio 45840 Phone: (419) 424-1828 | |
Walgreens #7683 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 15031 Sr 224 E, Findlay, Ohio 45840 Phone: (419) 420-0084 | |
Kroger Pharmacy 16327 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1996 Tiffin Ave, Findlay, Ohio 45840 Phone: (419) 427-3662 |